Melenhorst J, Koch S M, Uludag O, van Gemert W G, Baeten C G
Department of Surgery, University Hospital Maastricht, Maastricht, The Netherlands.
Colorectal Dis. 2008 Mar;10(3):257-62. doi: 10.1111/j.1463-1318.2007.01375.x. Epub 2007 Oct 19.
Sacral nerve modulation (SNM) for the treatment of faecal incontinence was originally performed in patients with an intact anal sphincter or after repair of a sphincter defect. There is evidence that SNM can be performed in patients with faecal incontinence and an anal sphincter defect.
Two groups of patients were analysed retrospectively to determine whether SNM is as effective in patients with faecal incontinence associated with an anal sphincter defect as in those with a morphologically intact anal sphincter following anal repair (AR). Patients in group A had had an AR resulting in an intact anal sphincter ring. Group B included patients with a sphincter defect which was not primarily repaired. Both groups underwent SNM. All patients had undergone a test stimulation percutaneous nerve evaluation (PNE) followed by a subchronic test over 3 weeks. If the PNE was successful, a permanent SNM electrode was implanted. Follow-up visits for the successfully permanent implanted patients were scheduled at 1, 3, 6 and 12 months and annually thereafter.
Group A consisted of 20 (19 women) patients. Eighteen (90%) had a positive subchronic test stimulation. Twelve patients had a successful SNM implant during middle-term follow-up. Group B consisted of 20 women. The size of the defect in the anal sphincter varied between 17% and 33% of the anal circumference. Fourteen (70%) had a positive subchronic test stimulation. Twelve patients had a successful SNM implant during middle-term follow-up. In both groups, the mean number of incontinence episodes decreased significantly with SNM (test vs baseline: P = 0.0001, P = 0.0002). There was no significant difference in resting and squeeze pressures during SNM in group A, but in group B squeeze pressure had increased significantly at 24 months. Comparison of patient characteristics and outcome between groups A and B revealed no statistical differences.
A morphologically intact anal sphincter is not a prerequisite for success in the treatment of faecal incontinence with SNM. An anal sphincter defect of <33% of the circumference can be effectively treated primarily with SNM without repair.
骶神经调节(SNM)最初用于治疗肛门括约肌完整或括约肌缺损修复后的大便失禁患者。有证据表明,SNM可用于治疗伴有肛门括约肌缺损的大便失禁患者。
对两组患者进行回顾性分析,以确定SNM在伴有肛门括约肌缺损的大便失禁患者中是否与肛门修复(AR)后肛门括约肌形态完整的患者一样有效。A组患者接受了AR,导致肛门括约肌环完整。B组包括未进行一期修复的括约肌缺损患者。两组均接受SNM治疗。所有患者均接受了经皮神经评估(PNE)试验刺激,随后进行了为期3周的亚慢性试验。如果PNE成功,则植入永久性SNM电极。对成功植入永久性电极的患者,安排在1、3、6和12个月进行随访,此后每年随访一次。
A组由20例(19名女性)患者组成。18例(90%)亚慢性试验刺激结果为阳性。12例患者在中期随访期间成功植入SNM。B组由20名女性组成。肛门括约肌缺损大小在肛门周长的17%至33%之间。14例(70%)亚慢性试验刺激结果为阳性。12例患者在中期随访期间成功植入SNM。两组中,SNM治疗后失禁发作的平均次数均显著减少(试验与基线比较:P = 0.0001,P = 0.0002)。A组SNM期间静息压力和挤压压力无显著差异,但B组在24个月时挤压压力显著增加。A组和B组患者特征和结局的比较无统计学差异。
肛门括约肌形态完整并非SNM治疗大便失禁成功的先决条件。周长<33%的肛门括约肌缺损可主要通过SNM有效治疗,无需修复。